Difference between revisions of "Bayer Healthcare - Animal Health"
From DolceraWiki
Abhay.goel (Talk | contribs) |
(No difference)
|
Latest revision as of 05:57, 16 September 2011
Go back to homepage
| Bayer Healthcare - Animal Health | |
| Financial Details | |
| Total Company Revenue in 2010 | $ 12 Bn |
| Revenue from Animal Health Market in 2010 | $ 0.8 Bn |
| % of revenue from Animal Health in 2010 | 6.67% |
| Segmentwise Revenue Breakup ($ Bn) | |
| Livestock Vaccines | 0.32 |
| Companion Vaccines | 0.48 |
| Number of Major Vaccines (Animal-wise) | |
| Poultry | 5 |
| Swine | 13 |
| Fish | 2 |
| Sheep | 1 |
| Cattle | 14 |
| Canine | 4 |
| Feline | 4 |
| Equine | 5 |
| Future Focus Areas | |
| Veterinary Vaccines under trial | 0 |
| Future Focus Areas of the company in the Veterinary Vaccines Market | The Animal Health Division focuses its research and development activities on antimicrobials, parasiticides and active substances useful for the treatment of non-infectious diseases such as renal failure, pain management, oncology, and congestive heart failure |
| Parasitology and drug delivery systems, chewable drug admisitration technology (cats and dogs); innovative mastitis and reproduction products, injectable solutions and suspensions, intra-ruminal devices, and sheep, cattle and equine parasiticides; | |
There are no Mergers and Acquisitions by Bayer Healthcare in Veterinary Vaccines segment
Go back to homepage
